Bipartisan bill to streamline U.S. response to foreign theft of IP may hasten clarity on biotech impact

As the biopharma industry awaits guidance from the government on the scope and potential impact of proposed technology export controls, a new congressional bill could help speed the process. Members of the Senate Select Committee on Intelligence introduced a bipartisan bill Friday that seeks to create a federal

Read the full 481 word article

How to gain access

Continue reading with a
two-week free trial.